CN111065636A - 稠合杂芳基衍生物、其制备方法及其在医药上的应用 - Google Patents

稠合杂芳基衍生物、其制备方法及其在医药上的应用 Download PDF

Info

Publication number
CN111065636A
CN111065636A CN201880058416.5A CN201880058416A CN111065636A CN 111065636 A CN111065636 A CN 111065636A CN 201880058416 A CN201880058416 A CN 201880058416A CN 111065636 A CN111065636 A CN 111065636A
Authority
CN
China
Prior art keywords
groups
group
compound
alkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201880058416.5A
Other languages
English (en)
Other versions
CN111065636B (zh
Inventor
张国宝
马殿强
贺峰
陶维康
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Shengdi Pharmaceutical Co ltd
Jiangsu Hengrui Medicine Co Ltd
Shanghai Hengrui Pharmaceutical Co Ltd
Original Assignee
Jiangsu Hengrui Medicine Co Ltd
Shanghai Hengrui Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd filed Critical Jiangsu Hengrui Medicine Co Ltd
Publication of CN111065636A publication Critical patent/CN111065636A/zh
Application granted granted Critical
Publication of CN111065636B publication Critical patent/CN111065636B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

提供一类稠合杂芳基衍生物、其制备方法及其在医药上的应用。具体而言,提供一种通式(I)所示的稠合杂芳基衍生物、其制备方法及含有该衍生物的药物组合物以及其作为治疗剂,特别是作为TLR7激动剂的用途,其中通式的各取代基与说明书中的定义相同。

Description

PCT国内申请,说明书已公开。

Claims (26)

  1. PCT国内申请,权利要求书已公开。
CN201880058416.5A 2017-09-22 2018-09-21 稠合杂芳基衍生物、其制备方法及其在医药上的应用 Active CN111065636B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710866425 2017-09-22
CN2017108664254 2017-09-22
PCT/CN2018/106983 WO2019057158A1 (zh) 2017-09-22 2018-09-21 稠合杂芳基衍生物、其制备方法及其在医药上的应用

Publications (2)

Publication Number Publication Date
CN111065636A true CN111065636A (zh) 2020-04-24
CN111065636B CN111065636B (zh) 2022-08-23

Family

ID=65810062

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880058416.5A Active CN111065636B (zh) 2017-09-22 2018-09-21 稠合杂芳基衍生物、其制备方法及其在医药上的应用

Country Status (3)

Country Link
CN (1) CN111065636B (zh)
TW (1) TW201915000A (zh)
WO (1) WO2019057158A1 (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102272134A (zh) * 2008-12-09 2011-12-07 吉里德科学公司 Toll样受体调节剂
CN102439011A (zh) * 2009-02-11 2012-05-02 加利福尼亚大学校务委员会 Toll样受体调节剂和疾病的治疗
WO2013117615A1 (en) * 2012-02-08 2013-08-15 Janssen R&D Ireland Piperidino-pyrimidine derivatives for the treatment of viral infections
CN107074860A (zh) * 2014-09-16 2017-08-18 吉利德科学公司 制备toll样受体调节剂的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD20170081A2 (ro) * 2015-03-04 2018-03-31 Gilead Sciences, Inc. Compuşi 4,6-diamino-pirido[3,2-D]pirimidină modulatori ai receptorilor de tip Toll

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102272134A (zh) * 2008-12-09 2011-12-07 吉里德科学公司 Toll样受体调节剂
CN103497192A (zh) * 2008-12-09 2014-01-08 吉里德科学公司 Toll 样受体调节剂
CN102439011A (zh) * 2009-02-11 2012-05-02 加利福尼亚大学校务委员会 Toll样受体调节剂和疾病的治疗
WO2013117615A1 (en) * 2012-02-08 2013-08-15 Janssen R&D Ireland Piperidino-pyrimidine derivatives for the treatment of viral infections
CN107074860A (zh) * 2014-09-16 2017-08-18 吉利德科学公司 制备toll样受体调节剂的方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EMMANUEL H. DEMONT ET AL.: "Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors", 《J. MED. CHEM》 *
PAUL BAMBOROUGH ET AL.: "Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors", 《J. MED. CHEM》 *

Also Published As

Publication number Publication date
WO2019057158A1 (zh) 2019-03-28
CN111065636B (zh) 2022-08-23
TW201915000A (zh) 2019-04-16

Similar Documents

Publication Publication Date Title
TWI760390B (zh) 吡唑並雜芳基類衍生物、其製備方法及其在醫藥上的應用
CN110177793B (zh) 杂芳基并吡唑类衍生物、其制备方法及其在医药上的应用
CN108794486B (zh) 稠环基酮类衍生物、其制备方法及其在医药上的应用
CN108948016B (zh) 嘌呤酮类衍生物、其制备方法及其在医药上的应用
CN111094289A (zh) 吡啶并嘧啶类衍生物、其制备方法及其在医药上的应用
CN110317202B (zh) 氰基吡咯并杂芳基类衍生物、其制备方法及其在医药上的应用
WO2022017365A1 (zh) 含硫异吲哚啉类衍生物、其制备方法及其在医药上的应用
US11932663B2 (en) Phosphorus imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof
CN111065636B (zh) 稠合杂芳基衍生物、其制备方法及其在医药上的应用
CA3234693A1 (en) Novel modulators of ehmt1 and ehmt2 and therapeutic use thereof
CN112574212B (zh) 一种嘧啶并五元氮杂环类衍生物、其制备方法及其在医药上的应用
CN111433201B (zh) 苯并氮杂䓬衍生物、其制备方法及其在医药上的应用
JP2020504109A (ja) アザビシクロ置換トリアゾール誘導体、その調製方法、及びその医薬用途
CN109694351B (zh) 苯并氮杂*衍生物、其制备方法及其在医药上的应用
CN109937205B (zh) 杂芳基并噻二嗪-2,2-二氧化物类衍生物、其制备方法及其在医药上的应用
CN109956903B (zh) 苯并氮杂䓬衍生物、其制备方法及其在医药上的应用
WO2023011608A1 (zh) 含三并环类衍生物调节剂、其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20230522

Address after: 222047 No. 7 Kunlun Shan Road, Lianyungang economic and Technological Development Zone, Jiangsu

Patentee after: JIANGSU HENGRUI MEDICINE Co.,Ltd.

Patentee after: Shandong Shengdi Pharmaceutical Co.,Ltd.

Patentee after: SHANGHAI HENGRUI PHARMACEUTICAL Co.,Ltd.

Address before: 222047 No. 7 Kunlun Shan Road, Lianyungang economic and Technological Development Zone, Jiangsu

Patentee before: JIANGSU HENGRUI MEDICINE Co.,Ltd.

Patentee before: SHANGHAI HENGRUI PHARMACEUTICAL Co.,Ltd.